[1]
Meng, R.P. et al. 2026. Clinical Efficacy of Early and Late Vedolizumab or Infliximab Interventions in Moderate Ulcerative Colitis: A Multicenter, Retrospective Cohort Study. Gastroenterology Research. 19, 1 (Jan. 2026), 35–42. DOI:https://doi.org/10.14740/gr2092.